
Palatin Technologies, Inc. is a clinical stage biopharmaceutical company developing [including FDA approval] best-in-class and first-in-class medicines based on peptide and small molecule therapeutics that modulate melanocortin receptor systems.
Address
CranburyNew Jersey
United States